EE03017B1 - Kõrge eriaktiivsusega ja teraapiliseks kasutamiseks sobiv vere XI hüübimisteguri kontsentraat ning meetod selle saamiseks - Google Patents

Kõrge eriaktiivsusega ja teraapiliseks kasutamiseks sobiv vere XI hüübimisteguri kontsentraat ning meetod selle saamiseks

Info

Publication number
EE03017B1
EE03017B1 EE9400003A EE9400003A EE03017B1 EE 03017 B1 EE03017 B1 EE 03017B1 EE 9400003 A EE9400003 A EE 9400003A EE 9400003 A EE9400003 A EE 9400003A EE 03017 B1 EE03017 B1 EE 03017B1
Authority
EE
Estonia
Prior art keywords
concentrate
specific activity
high specific
therapeutic use
preparation
Prior art date
Application number
EE9400003A
Other languages
English (en)
Estonian (et)
Inventor
Burnouf Miryana
Dernis Dominique
Original Assignee
Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord filed Critical Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord
Publication of EE03017B1 publication Critical patent/EE03017B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EE9400003A 1991-05-07 1994-05-23 Kõrge eriaktiivsusega ja teraapiliseks kasutamiseks sobiv vere XI hüübimisteguri kontsentraat ning meetod selle saamiseks EE03017B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105572A FR2676231A1 (fr) 1991-05-07 1991-05-07 Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.

Publications (1)

Publication Number Publication Date
EE03017B1 true EE03017B1 (et) 1997-08-15

Family

ID=9412593

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400003A EE03017B1 (et) 1991-05-07 1994-05-23 Kõrge eriaktiivsusega ja teraapiliseks kasutamiseks sobiv vere XI hüübimisteguri kontsentraat ning meetod selle saamiseks

Country Status (16)

Country Link
US (1) US5252217A (he)
EP (1) EP0512883B1 (he)
AT (1) ATE156360T1 (he)
AU (1) AU652043B2 (he)
BR (1) BR9201718A (he)
CA (1) CA2068069C (he)
DE (1) DE69221369T2 (he)
DK (1) DK0512883T3 (he)
EE (1) EE03017B1 (he)
ES (1) ES2107511T3 (he)
FR (1) FR2676231A1 (he)
GR (1) GR3025134T3 (he)
IL (1) IL99567A (he)
LT (1) LT3417B (he)
RU (1) RU2097047C1 (he)
UA (1) UA27733C2 (he)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2151604C1 (ru) * 1999-01-21 2000-06-27 Станкевич Виктор Евгеньевич Способ приготовления универсальной гемотрансфузионной среды
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
KR20040015821A (ko) * 2001-07-20 2004-02-19 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물
US20050181978A1 (en) * 2003-11-20 2005-08-18 Rasmus Rojkjaer Therapeutic use of factor XI
WO2005049070A1 (en) * 2003-11-20 2005-06-02 Novo Nordisk Health Care Ag Therapeutic use of factor xi
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
AR062711A1 (es) * 2006-09-08 2008-11-26 Wyeth Corp Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad
US20100062512A1 (en) * 2007-01-04 2010-03-11 Crucell Holland B.V. Purification of factor xi
EP2379084B1 (en) * 2008-10-15 2017-11-22 Ionis Pharmaceuticals, Inc. Modulation of factor 11 expression
FR2974366B1 (fr) 2011-04-20 2016-06-24 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur xi
FR2974301B1 (fr) * 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
IL212911A0 (en) 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
DE102012022234A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Einstufiges Verfahren zur Reinigung von (Blut)Plasmaproteinen wie Albumin aus Gemischen
DE102012022233A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Verfahren zur Reinigung eines (Blut)plasmaproteins
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법
JP7438135B2 (ja) 2018-05-09 2024-02-26 アイオーニス ファーマシューティカルズ， インコーポレーテッド Ｆｘｉの発現を低下させるための化合物及び方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859340A (en) * 1976-03-15 1989-08-22 Cuno, Incorporated Filter sheet
US4783262A (en) * 1987-03-30 1988-11-08 Cuno Incorporated Separator for cell type filter element

Also Published As

Publication number Publication date
UA27733C2 (uk) 2000-10-16
CA2068069A1 (en) 1992-11-08
EP0512883A1 (fr) 1992-11-11
GR3025134T3 (en) 1998-02-27
US5252217A (en) 1993-10-12
DE69221369D1 (de) 1997-09-11
DK0512883T3 (da) 1998-03-16
LTIP265A (en) 1994-10-25
AU1526392A (en) 1992-11-12
IL99567A0 (en) 1992-08-18
AU652043B2 (en) 1994-08-11
BR9201718A (pt) 1992-12-29
FR2676231A1 (fr) 1992-11-13
CA2068069C (en) 2005-03-15
EP0512883B1 (fr) 1997-08-06
ATE156360T1 (de) 1997-08-15
FR2676231B1 (he) 1995-04-21
DE69221369T2 (de) 1998-03-19
IL99567A (he) 1996-01-19
LT3417B (en) 1995-09-25
RU2097047C1 (ru) 1997-11-27
ES2107511T3 (es) 1997-12-01

Similar Documents

Publication Publication Date Title
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
GR3024263T3 (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
NO880022L (no) Fremstilling av m-csf.
FI964341L (fi) Prosessi ja laitteisto, joilla vähennetään kehon tietyissä kohdissa olevaa rasvakudosta yhdistetyllä lämpökäsittelyllä ja lihastoiminnalla
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
IT1219874B (it) Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche
DE3782498D1 (de) Verwendung von granulozyt-makrophagen-kolonie erregenden faktor zur herstellung eines medikaments zur behandlung von bakterieller krankheiten.
FI854219A7 (fi) Lipoproteiineja adsorboiva aine käytettäväksi kehon ulkopuolisessa kiertokäsittelyssä ja menetelmä sen valmistamiseksi.
ZA906544B (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
FI875319A7 (fi) Bisyklisten aminokarboksyylihappojen johdannaiset, menetelmä niiden valmistamiseksi ja niiden valmistuksessa käytettävät välituotteet, sekä niiden käyttö
IE871567L (en) Method for treating depression
HUT40695A (en) Dna sequences, recombinant dna molecules and processes for preparing humane lipocortine like polypeptides
ATE56976T1 (de) Peptidderivate mit lactonischer oder zykloamidischer struktur, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
IT8748129A0 (it) Procedimento per la tintura in sezione delle pelli
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
ATE40795T1 (de) Verwendung eines zerebral und peripher wirkenden antihypoxidotikums.
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
FR2584605B1 (fr) Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
RO82337A2 (ro) Bomboane medicinale pentru tratamentul afectiunilor buco-faringiene la copii
ES2043142T3 (es) Procedimiento para la obtencion de (+)-1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de (2-(n-metil-n-fenilmetilamino)etilo) fumarato.
RU94031049A (ru) Способ лечения дисфункциональных расстройств организма человека
FR2563738B1 (fr) Appareil pour l'amelioration de la circulation du sang et de la respiration
DE58901297D1 (de) Noremopamil, seine herstellung und verwendung.
AU7931487A (en) Therapeutic treatment of abnormal cell growth with follicle regulatory protein

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

MM4A Lapsed by not paying the annual fees

Effective date: 20100523